Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...

The persistent corneal edema market is experiencing steady growth, driven by rising clinical awareness, improved postoperative monitoring, and growing focus on endothelial dysfunction-related ...

An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 ...

Thiruvananthapuram General Hospital has created history by successfully performing a corneal transplant surgery, the first of its kind to be conducted at a district-level hospital in India. The ...